Regulatory toxicology considerations for the development of inhaled pharmaceuticals

References

• Alexander, D. J., Collins, C. J., Coombs, D. W., Gilkeson, I. S., Hardy, C. J., Healey, G., et al. (2008). Association of Inhalation Toxicologists (AIT) working party recommendation for standard delivered dose calculation and expression in non-clinical aerosol inhalation toxicology studies with pharmaceuticals. Inhal Toxicol 20:1179–1189.
   PubMed Web of Science ®Google Scholar
• Bennett, J. A., Harrison, T. W., Tattersfield, A. E. (1999). The contribution of the swallowed fraction of an inhaled dose of salmeterol to it systemic effects. Eur Respir J 13:445–448.
   PubMed Web of Science ®Google Scholar
• Bermudez, E., Mangum, J. B., Asgharian, B., Wong, B. A., Reverdy, E. E., Janszen, D. B., et al. (2002). Long-term pulmonary responses of three laboratory rodent species to subchronic inhalation of pigmentary titanium dioxide particles. Toxicol Sci 70:86–97.
   PubMed Web of Science ®Google Scholar
• Bide, R. W., Armour, S. J., Yee, S. (2000). Allometric respiration/body mass data for animals to be used for estimates of inhalation of toxicology to young adult humans. J Appl Toxicol 20:273–290.
   PubMed Web of Science ®Google Scholar
• British Heart Foundation. (2011). Facts about respiratory diseases. Available at: http://www.lunguk.org/media-and-campaigning/media-centre/lung-stats-and-facts/factsaboutrespiratorydisease.htm. Accessed April 2011. 15th April 2011.
   Google Scholar
• Brock, W. J., Trochimowicz, H. J., Farr, C. H., Millischer, R-J., Rusch, G. M. (1996). Acute, subchronic, and developmental toxicity and genotoxicity of 1,1,1-trifluoroethane (HFC-143a). Toxicol Sci 31:200–209.
   Google Scholar
• Buckley, L. A., Morgan, K. T., Swenberg, J. A., James, R. A., Hamm, T. E., Jr., Barrow, C. S. (1985). The toxicity of dimethylamine in F-344 rats and B6C3F1 mice following 1-year inhalation exposure. Fundam Appl Toxicol 5:341–352.
   PubMedGoogle Scholar
• Dahl, A. R. (1995). Metabolic charateristics of the respiratory tract. In: Concepts in inhalation toxicology, 2nd ed. (pp. 141–160). Washington, DC: Taylor and Francis.
   Google Scholar
• Dahl, A. R., Gerde, P. (1994). Uptake and metabolism of toxicants in the respiratory tract. Environ Health Perspect 102(Suppl 11):67–70.
   PubMedGoogle Scholar
• DeGeorge, J. J., Ho Ahn, C., Andrews, P. A., Brower, M. E., Choi, Y. S., Chun, M. Y., et al. (1997). Considerations for toxicology studies of respiratory drug products. Regul Toxicol Pharmacol 25:189–193.
   PubMed Web of Science ®Google Scholar
• Dodd, D. E., Leahy, F. H., Feldman, M. L., English, J. H., Vinegar, A. (1999). Reproductive toxicity screen of trifluoroiodomethane (CF3I) in Sprague-Dawley rats. Inhal Toxicol 11:1041–1055.
   PubMed Web of Science ®Google Scholar
• Dormons, J. A. M. A., Van Bree, L. (1995). Function and response of type II cells to inhaled toxicants. Inhal Toxicol 7:319–342.
   Web of Science ®Google Scholar
• Drew, R. T. (1990). Basic principles of inhalation exposure. J Am Coll Toxicol 9:389–396.
   Google Scholar
• Driscoll, K. E., Carter, J. N. M., Howard, B. W., et al. (1996). Pulmonary inflammatory chemokine and mutagenic responses in rats after sub-chronic inhalation of carbon black. Toxicol Appl Pharmacol 136:372–380.
   PubMed Web of Science ®Google Scholar
• Driscoll, K. E., Costa, D. L., Hatch, G., Henderson, R., Oberdorster, G., Salem, H., et al. (2000). Intratracheal instillation as an exposure technique for the evaluation of respiratory tract toxicity: uses and limitations. Toxicol Sci 55:24–35.
   PubMed Web of Science ®Google Scholar
• Dudley, R. E., Patterso, S. E., Machotka, S. V., Kesterson, J. W. (1989). One month inhalation study of tolobuterol hydrochloride in rats and dogs. Fundam Appl Toxicol 13:694–701.
   PubMedGoogle Scholar
• Elder, A., Gelein, R., Finkelstein, J. N., Driscoll, K. E., Harkema, J., Oberdörster, G. (2005). Effects of subchronically inhaled carbon black in three species. 1. Retention kinetics, lung inflammation, and histopathology. Toxicol Sci 88:614–629.
   Google Scholar
• EMEA. (2005). Guideline on the evaluation of control samples in nonclinical safety studies: checking for contamination with the test substance. CPMP/SWP/1094/04.
   Google Scholar
• Forbes, B., Asgharian, B., Dailey, L. A., Ferguson, D., Gerde, P., Gumbleton, M., et al. (2011). Challenges in inhaled product development and opportunities for open innovation. Adv Drug Deliv Rev 63:69–87.
   PubMed Web of Science ®Google Scholar
• Gopinath, C., Prentice, D. E., Lewis, D. J. (1987). The respiratory system. In: Gresham, G. A. (Ed.), Atlas of experimental toxicological pathology. Current histopathology (vol. 13; pp. 22–40). Boston, Massachusetts, USA: MTP Press.
   Google Scholar
• Greaves, P. (2007). Respiratory tract. In: Histopathology of preclinical toxicity studies: interpretation and relevance in drug safety evaluation, 3rd ed. (pp. 215–269). New York: Elsevier.
   Google Scholar
• Hardy, C. (2008). Non-clinical safety assessment of inhaled biopharmaceuticals. Dev Life Sci 8:16–18.
   Google Scholar
• Henderson, R. F. (1984). Use of bronchoalveolar lavage to detect lung damage. Environ Health Perspect 56:115–129.
   PubMed Web of Science ®Google Scholar
• Henderson, R. F. (2005). Use of bronchoalveolar lavage to detect respiratory tract toxicity of inhaled material. Exp Toxicol Path 57:155–159.
   PubMed Web of Science ®Google Scholar
• Inchiosa, M. A. (2006). Toxicokinetics: deposition, absorption, distribution, and excretion. In: Salem, H., Katz, S. A., ed, Inhalation toxicology, 2nd ed. (pp. 405–439). New York: Taylor and Francis.
   Google Scholar
• International Conference on Harmonization (ICH). (1995). Topic S3A. Note for guidance on toxicokinetics: a guidance for assessing systemic exposure in toxicology studies. CPMP/ICH/384/95. Geneva, Switzerland: ICH.
   Google Scholar
• International Conference on Harmonization (ICH). (2009). Topic M3 (R2). Non-clinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals. CPMP/ICH/286/95. Geneva, Switzerland: ICH.
   Google Scholar
• International Conference on Harmonization (ICH). (2011). Topic S6 (R1). Preclinical safety evaluation of biotechnology-derived pharmaceuticals. CHMP/ICH/731268/1998. Geneva, Switzerland: ICH.
   Google Scholar
• International Life Sciences Institute (ILSI). (2000). The relevance of the rat lung response to article overload for human risk assessment: a workshop consensus report. Inhal Toxicol 12:1–17.
   Google Scholar
• Issar, M., Mobley, C., Khan, P., Hochhaus, G. (2004). Pharmacokinetics and pharmacodynamics of drug delivery to the lungs. In: Hickey, A. J., (Ed.), Pharmaceutical inhalation aerosol technology, 2nd ed (pp. 198–233). New York: Marcel Dekker.
   Google Scholar
• Kaufmann, W., Bader, R., Ernst, H., Harada, T., Hardisty, J., Kittel, B., et al. (2009). 1st International ESTP Expert Workshop: “Larynx squamous metaplasia”. A re-consideration of morphology and diagnostic approaches in rodent studies and its relevance for human risk assessment. Exp Toxicol Pathol 61:591–603.
   Google Scholar
• Leach, C. L. (2007). Inhalation aspects of therapeutic aerosols. Toxicol Pathol 35:23–26.
   PubMed Web of Science ®Google Scholar
• Lee, K. P., Henry, N. W., Trochimowicz H.J., Reinhardt, C. F. (1986). Pulmonary responses to impaired lung clearance following excessive TiO2 dust deposition. Environ Res 41:144–167.
   PubMed Web of Science ®Google Scholar
• Lee, K. P., Frame, S. R., Sykes, G. P., Valentine, R. (1993). Testicular degeneration and spermatid retention in young male rats. Toxicol Pathol 21:292–302.
   PubMed Web of Science ®Google Scholar
• Lewis, D. J. (1981). Factors affecting the distribution of tobacco smoke-induced lesions in the rodent larynx. Toxicol Lett 9:189–194.
   PubMed Web of Science ®Google Scholar
• Lewis, D. J. (1991). Morphological assessment of pathological changes within the rat larynx. Toxicol Pathol 19:352–357.
   PubMed Web of Science ®Google Scholar
• Lipworth, B. J. (1996). Pharmacokinetics of inhaled drugs. Br J Clin Pharm 42:697–705.
   PubMed Web of Science ®Google Scholar
• Miller, F. J. (2000). Dosimetry of particles in laboratory animals and humans in relationship to issues surrounding lung overload and human risk assessment. Inhal Toxicol 12:19–57.
   PubMed Web of Science ®Google Scholar
• Miller, R. A., Renne, R. A. (1996). Effects of xenobiotics on the larynx of the rat, mouse, and hamster. In Jones, T. C., Dungworth, D. L., Mohr, U., (Eds.), Respiratory system, 2nd ed., (pp. 51–57). ILSI monographs on pathology of laboratory animals. New York: Springer-Verlag.
   Google Scholar
• Morgan, K. T. (1991). Approaches to the identification and recording of nasal lesions in toxicology studies. Toxicol Pathol 19:337–351.
   PubMed Web of Science ®Google Scholar
• Morrow, P. E. (1986). The setting of particulate exposure levels for chronic inhalation toxicity studies. J Am Coll Toxicol 5:533–544.
   Google Scholar
• Morrow, P. E. (1992). Dust overloading of the lungs: update and appraisal. Toxicol Appl Pharmacol 113:1–12.
   PubMed Web of Science ®Google Scholar
• Nave, R., Watz, H., Hoffman, H., Boss, H., Magnussen, H. (2010). Deposition and metabolism of inhaled ciclesonide in the human lung. Eur Respir J 36:1113–1119.
   PubMed Web of Science ®Google Scholar
• Newman, S. P., Pitcairn, G. R., Hirst, P. H., Rankin, L. (2003). Radionuclide imaging technologies and their use in evaluating asthma drug deposition in the lungs. Adv Drug Deliv Rev 55:851–867.
   PubMed Web of Science ®Google Scholar
• Okazaki, S., Yamazaki, K., Tanmura, T., Hoshiya, T., Anabuki, K., Tanaka, H., et al. (1992). [A 13-week subcutaneous toxicity study of prednisolone farnesylate (PNF) in rats]. [Article in Japanese] J Toxicol Sci 17:1–48.
   PubMedGoogle Scholar
• Organization for Economic Co-operation and Development (OECD). (2009a). OECD guidance document on histopathology for inhalation toxicity studies, supporting TG 412 (subacute inhalation toxicity: 28 day) and TG 413 (subchronic inhalation toxicity: 90 day). Draft version, 28 September 2009. Available at: www.oecd.org/dataoecd/45/2/43822718.pdf. AccessedAugust 2011. 3rd August 2011.
   Google Scholar
• Organization for Economic Co-operation and Development (OECD). (2009b). OECD guidelines for the testing of chemicals, section 4: health effects. Guideline 412. Subacute inhalation toxicity: 28-day study. Available at: www.oecd-ilibrary.org/environment/oecd-guidelines-for-the-testing-of-chemicals-section-4-health-effects_20745788. Accessed September 2011. 1st Sept 2011.
   Google Scholar
• Osimitz, T. G., Droege, W., Finch, J. M. (2007). Toxicologic significance of histologic change in the larynx of the rat following inhalation exposure: a critical review. Toxicol Appl Pharmacol 225:229–237.
   PubMed Web of Science ®Google Scholar
• Owen, K. (2009). Preclinical toxicology for inhaled drugs—practicalities and implications. J Aerosol Med Pulm Drug Deliv 22:304.
   Google Scholar
• Owen, K., Beck, S. L., Damment, S. J. P. (2010). The preclinical toxicology of salmeterol hydroxynaphthoate. Hum Exp Toxicol 29:393–407.
   PubMed Web of Science ®Google Scholar
• Pauluhn, J. (2008). Inhalation toxicology: methodological and regulatory challenges. Exp Toxicol Pathol 60:111–124.
   PubMed Web of Science ®Google Scholar
• Raabe, O. G., Al-Bayati, M. A., Teague, S. V., Rasolt, A. (1988). Regional deposition of inhaled monodisperse coarse and fine aerosol particles in small laboratory animals. Ann Occup Hyg 32:53–63.
   Google Scholar
• Renne, R. A., Gideon, K. M. (2006). Types and patterns of response in the larynx following inhalation. Toxicol Pathol 34:281–285.
   PubMed Web of Science ®Google Scholar
• Renne, R. A., Gideon, K. M., Harbo, S. J., Staska, L. M., Grumbein, S. L. (2007). Upper respiratory tract lesions in inhalation toxicology. Toxicol Pathol 35:163–169.
   PubMed Web of Science ®Google Scholar
• Rubkin, B. K. (2010). Air and soul: the science and application of aerosol therapy. Respir Care 55:911–921.
   PubMed Web of Science ®Google Scholar
• Schlesinger, R. B. (1985). Comparative deposition of inhaled aerosols in experimental animals and humans: a review. J Toxicol Environ Health 15:197–214.
   PubMed Web of Science ®Google Scholar
• Shoyele, S. A., Cawthorne, S. (2006). Particle engineering techniques for inhaled biopharmaceuticals. Adv Drug Deliv Rev 58:1009–1029.
   PubMed Web of Science ®Google Scholar
• Snipes, M. B. (1989). Long-term retention and clearance of particles inhaled by mammalian species. Crit Rev Toxicol 20:175–211.
   PubMed Web of Science ®Google Scholar
• Snipes, M. B. (1995). Pulmonary retention of particles and fibers. In: Concepts in inhalation toxicology, 2nd ed. (pp. 193–227). Washington, DC: Taylor and Francis.
   Google Scholar
• (SOT). (1992). Technical committee of the Inhalation Speciality Section. Society of Toxicology (SOT) recommendations for the conduct of acute inhalation limit tests. Fundam Appl Toxicol 18:321–327.
   PubMedGoogle Scholar
• Somers, G. I., Lindsay, N., Lowdon, B. A., Jones, A. E., Freathy, C., Ho, S., et al. (2007). A comparison of the expression and metabolizing activities of phase I and II enzymes in freshly isolated human lung parenchymal cells and cryopreserved human hepatocytes. Drug Metab Dispos 35:1797–1805.
   PubMed Web of Science ®Google Scholar
• Thorsson, L., Edsbacker, S., Conradson, T-B. (1994). Lung desposition of budesonide from Turbohaler is twice that from a pressurized metered dose inhaler P-MDI. Eur Respir J 7:1839–1844.
   PubMed Web of Science ®Google Scholar
• Turton, J., Hooson, J. (1998). The respiratory system. In: Target organ pathology: a basic text (pp. 347–351). Washington, DC: Taylor and Francis.
   Google Scholar
• U.S. FDA. (2000). NDA 021-077. Drug approval package: Advair diskus (fluticasone propionate and salmeterol xinafoate) inhalation powder—FDA review. Approval date: 24 August 2000. Available at: www.accessdata.fda.gov/drugsatfda_docs/nda/2000/21077_AdvairDiskus.cfm. Accessed 5th June 2011.
   Google Scholar
• U.S. FDA. (2006). NDA 021–247. Drug approval package: Aerospan (flunisolide HFA, 80 mcg) inhalation aerosol—FDA review. Approval date: 27 January 2006. Available at:http://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/021247_aerospan_toc.cfm. Accessed 5th June 2011.
   Google Scholar
• Wadher, K., Kalsait, R., Umekar, M. (2011). Pulmonary insulin delivery: challenges and current status. J Pharmaceut Sci Res 3:1052–1059.
   Google Scholar
• Warheit, D. B., Hansen, J. F., Yuen, I. S., Kelly, D. P., Snajdr, S. I., Hartsky, M. A. (1997). Inhalation of high concentrations of low toxicity dusts in rats results in impaired pulmonary clearance mechanisms and persistent inflammation. Toxicol Appl Pharmacol 145:10–22.
   PubMed Web of Science ®Google Scholar
• Webber, C. (2005). Inhaled-dose ADME studies. Dev Life Sci 6:10–13.
   Google Scholar
• Whalan, J. E., Redden, J. C. (1994). Interim policy for particle size and limit concentration issues in inhalation toxicity sudies. U.S. EPA. Available at: cfpub.epa.gov/ncea/cfm/recordisplay.cfm?deid = 186068. Accessed September 2011. 2nd Sept 2011.
   Google Scholar
• Wilson, A. (1987). Aerosol dynamics and delivery systems. In: Jenne, J. W., Murphy, S., (Eds.), Drug therapy for asthma: research and clinical practice (pp. 389–412). New York: Marcel Dekker.
   Google Scholar
• Witschi, H., Last, J. A. (2001). Toxic responses of the respiratory system. In: Klassen, C., (Eds), Casarett and Doull’s toxicology, 6th ed. (pp. 515–534). New York: McGraw-Hill Medical Publishing Division.
   Google Scholar
• Wolff, R. K. (1998). Safety of inhaled proteins for therapeutic use. J Aerosol Med 11:197–219.
   PubMedGoogle Scholar
• Wong, B. A. (2007). Inhalation exposure systems: design, methods, and operation. Toxicol Pathol 35:3–14.
   PubMed Web of Science ®Google Scholar
• World Heath Organization. (2008). Factsheet 310: top 10 causes of death. Available at: www.who.int/mediacentre/factsheets/fs310_2008.pdf. Accessed April 2011. 14th April 2011.
   Google Scholar
• Young, S. L., Silbajoris, R. (1986). Dexamethasone increases adult rat lung surfactant lipids. J Appl Physiol 60:1665–1672.
   PubMed Web of Science ®Google Scholar